Price Alert

Caladrius Biosciences Inc... (CLBS)

NASDAQ: CLBS · Real-Time Price · USD

0.43

-0.08 (-16.05%)

At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net Income	-6.63M	-4.23M	-6.79M	-6.93M	-5.68M	-8.06M
Depreciation & Amortization	7K	7K	8K	14K	17K	16K
Stock-Based Compensation	368K	760K	-374K	772K	270K	597K
Other Working Capital	286K	-912K	-23K	310K	-42K	-1.68M
Other Non-Cash Items	385K	515K	955K	792K	810K	323K
Deferred Income Tax	n/a	n/a	374K	n/a	n/a	n/a
Change in Working Capital	804K	-2.7M	1.23M	310K	-42K	-848K
Operating Cash Flow	-5.06M	-5.64M	-4.6M	-5.04M	-4.63M	-7.97M
Capital Expenditures	-235K	n/a	-60K	n/a	-60K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-3.75M	-26.55M	-42.45M	-31.54M	-29.88M	-75.91M
Sales Maturities Of Investments	39.61M	20.46M	58.9M	36.48M	18.74M	10.82M
Other Investing Acitivies	-10M	n/a	60K	n/a	n/a	n/a
Investing Cash Flow	25.63M	-6.09M	16.46M	4.94M	-11.2M	-65.09M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	29K	-168K	21K	-64K	22K	85.3M
Financial Cash Flow	29K	-168K	21K	-64K	22K	85.3M
Net Cash Flow	20.6M	-11.9M	11.88M	-163K	-15.81M	12.23M
Free Cash Flow	-5.3M	-5.64M	-4.66M	-5.04M	-4.69M	-7.97M